IV sedation for implant cases: is there a safer way?
16 May 2026
ADI Implant theatre
C
Learning Content
IV sedation in primary care follows IACSD 2020, often limiting use to benzodiazepines, which can be challenging for longer implant cases. This session explores Remimazolam for extended sedation, offering a predictable, controllable approach with rapid recovery for full arch implant.
Aims
To highlight the standards surrounding more complex sedation for implant care - To highlight the need for dedicated sedationists in complex cases - To present modern safer techniques to treat more patients and give a more pleasurable experience for patients.
Learning Outcomes
- Understand the concept of increasing the complexity of procedures with complex sedation -Understand the IACSD standards and how they relate to the safe use of sedatives - Appreciate the benefits of Remimazolam in the safe sedation of patients.
.png){kind=logo}
